Executive Vice President, Accord Healthcare
Meet The Team
Executive Vice President, Accord Healthcare
Paul has over 25 years’ experience in the pharmaceutical industry, predominantly on the speciality and biosimilar side of the business. On biosimilars Paul was the first to fully commercialise 3 biosimilars in a regulated market, collaboratively setting up the Biosimilar division of BGMA and acting as Vice Chair.
Paul joined Accord in 2018, where he led the strategy of Accord’s Speciality Brands division, playing a significant role in helping Accord to be one of the biggest suppliers of oncology medicines in Europe. Paul’s pharma experience includes UK, Europe and Global management roles in commercial, business development and general management positions.
Since July 2021, Paul has led Accord’s operations in the EMENA territory, with responsibility for implementing and delivering the company’s mission to increase access to high quality medicines within the region with an exceptional pipeline of generic, biosimilar and novel medicines and is responsible for a turnover of $1bn with over 2000 employees.
Global SVP Business Development, Portfolio & Strategy
Àlex has over 20 years’ experience in the pharmaceutical sector. Àlex started his career in International Trade within the purchasing division of a major active ingredient company and later became one of Accord Healthcare’s very first and pivotal hires. Àlex has been instrumental in the growth of the company, from its initial set up as a legal entity through its evolution to becoming a major healthcare player and one of fastest growing pharmaceuticals companies in Europe. Currently, Àlex leads Accord’s Global Portfolio and Business Development function which includes several the company’s cornerstone diversification initiatives, including Animal Health.
Commercial Lead, Animal Health EMENA
With over 20 plus years in healthcare, with significant experience in marketing, Bob’s healthcare experience includes working for one of the world’s largest medical devices companies, Boston Scientific where he led the International marketing and communications strategy for four divisions. Before transitioning to a start-up human health and diagnostics company leading the global marketing, business information and customer services functions.
In 2011, Bob was approached to move into Animal Health, joining Norbrook Laboratories, one of Europe’s leading generic manufactures, with responsibility for and working across Global Marketing, General Management, Global Alliances and finally, Sales Operations. Bob joined Accord Healthcare in 2022 where is responsible for leading Accord’s diversification strategy in Animal Health across EMENA.
Paul has over 25 years’ experience in the pharmaceutical industry, predominantly on the speciality and biosimilar side of the business. On biosimilars Paul was the first to fully commercialise 3 biosimilars in a regulated market, collaboratively setting up the Biosimilar division of BGMA and acting as Vice Chair.
Paul joined Accord in 2018, where he led the strategy of Accord’s Speciality Brands division, playing a significant role in helping Accord to be one of the biggest suppliers of oncology medicines in Europe. Paul’s pharma experience includes UK, Europe and Global management roles in commercial, business development and general management positions.
Since July 2021, Paul has led Accord’s operations in the EMENA territory, with responsibility for implementing and delivering the company’s mission to increase access to high quality medicines within the region with an exceptional pipeline of generic, biosimilar and novel medicines and is responsible for a turnover of $1bn with over 2000 employees.
Àlex has over 20 years’ experience in the pharmaceutical sector. Àlex started his career in International Trade within the purchasing division of a major active ingredient company and later became one of Accord Healthcare’s very first and pivotal hires. Àlex has been instrumental in the growth of the company, from its initial set up as a legal entity through its evolution to becoming a major healthcare player and one of fastest growing pharmaceuticals companies in Europe. Currently, Àlex leads Accord’s Global Portfolio and Business Development function which includes several the company’s cornerstone diversification initiatives, including Animal Health.
With over 20 plus years in healthcare, with significant experience in marketing, Bob’s healthcare experience includes working for one of the world’s largest medical devices companies, Boston Scientific where he led the International marketing and communications strategy for four divisions. Before transitioning to a start-up human health and diagnostics company leading the global marketing, business information and customer services functions.
In 2011, Bob was approached to move into Animal Health, joining Norbrook Laboratories, one of Europe’s leading generic manufactures, with responsibility for and working across Global Marketing, General Management, Global Alliances and finally, Sales Operations. Bob joined Accord Healthcare in 2022 where is responsible for leading Accord’s diversification strategy in Animal Health across EMENA.
Key Account Manager, Animal Health UK & Ireland
Jess Coggins has worked within the veterinary medicines industry for over 10 years across sales, practice & buying group procurement roles for companion animals, equine and livestock. Jess has significant commercial experience across nutraceuticals generics companies and novel and highly technical vaccines as well as procurement of veterinary medicines and consumable products for a large mixed-species veterinary practice.
Key Account Manager, Animal Health UK & Ireland
Gemma Young has over 17 years’ of experience in the Animal health industry. She has worked in companion animal and large animal pharmaceuticals, a National E-commerce role supporting animal health online and pet store retailers and more recently in a startup Biotech animal health company working on global market initiatives.
Regulatory Lead Animal Health
Having worked within regulatory affairs for veterinary pharmaceutical companies for 6+ years, Laeka has come on board to help get our products onto the market. She initially worked for one of the leading European generics companies, where she was locally responsible for quality, pharmacovigilance, and regulatory affairs, as well as operations and finance. She has worked with generic and novel products in companion and farm animal medicines within the EU, UK, and other countries worldwide.
Quality Lead, Animal Health
Kelly has been employed at Accord’s manufacturing facility in the UK since 2010 and has over 15 years of experience in the highly regulated pharmaceutical industry, specifically in Quality Assurance. She possesses substantial expertise in UK and European regulatory compliance, along with the associated Good Manufacturing and Distribution Practice (GMDP) requirements.
Recently, Kelly joined the Accord Animal Health Team to help integrate and implement a compliant, effective, and scalable Quality Management System for Accord Animal Health products across both the UK and European markets.
Jess Coggins has worked within the veterinary medicines industry for over 10 years across sales, practice & buying group procurement roles for companion animals, equine and livestock. Jess has significant commercial experience across nutraceuticals generics companies and novel and highly technical vaccines as well as procurement of veterinary medicines and consumable products for a large mixed-species veterinary practice.
Gemma Young has over 17 years’ of experience in the Animal health industry. She has worked in companion animal and large animal pharmaceuticals, a National E-commerce role supporting animal health online and pet store retailers and more recently in a startup Biotech animal health company working on global market initiatives.
Having worked within regulatory affairs for veterinary pharmaceutical companies for 6+ years, Laeka has come on board to help get our products onto the market. She initially worked for one of the leading European generics companies, where she was locally responsible for quality, pharmacovigilance, and regulatory affairs, as well as operations and finance. She has worked with generic and novel products in companion and farm animal medicines within the EU, UK, and other countries worldwide.
Kelly has been employed at Accord’s manufacturing facility in the UK since 2010 and has over 15 years of experience in the highly regulated pharmaceutical industry, specifically in Quality Assurance. She possesses substantial expertise in UK and European regulatory compliance, along with the associated Good Manufacturing and Distribution Practice (GMDP) requirements.
Recently, Kelly joined the Accord Animal Health Team to help integrate and implement a compliant, effective, and scalable Quality Management System for Accord Animal Health products across both the UK and European markets.